• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    MesoPher Increases RFS Rate In Pancreatic Cancer; Orphan Status

    BUSINESSWIRE

    Amphera Announces a Positive Opinion of EMA on the Granting of Orphan Medicinal Product Designation for MesoPher

    BUSINESSWIRE

    Amphera reports topline results from MesoPher cell therapy trials

    CLINICALTRIALSARENA

    Amphera Announces Clinical Updates of MesoPher Cell Therapy

    BUSINESSWIRE

    Last patient completed followup period in PII/III study of MesoPher cell therapy

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.